Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.
about
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseProstatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients.Effects of obesity on prostate volume and lower urinary tract symptoms in korean menEpidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score.PGDB: a curated and integrated database of genes related to the prostateCan metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.Development and validation of an LC-MS assay for finasteride and its application to prostate cancer prevention trial sample analysisEpidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction.Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia.Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia.Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.Cadaveric and radiologic study of the anatomical variations of the prostatic arteries: A review of the literature and a new classification proposal with application to prostatectomy.Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.The prevalence of lower urinary tract symptoms in a Chinese population, and the correlation with uroflowmetry and disease perception.Prevalence of BPH and lower urinary tract symptoms in West Africans.Heterogeneous copper concentrations in cancerous human prostate tissues.Epidemiology of senile prostatic enlargement among elderly men in Arar, Kingdom of Saudi ArabiaEndoscopic ablation for benign enlargement of the prostate.Embolization therapy for benign prostatic hyperplasia: influence of embolization particle size on gland perfusion.BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia.27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells.Role of Poor Urethral Sphincter Relaxation in Men with Voiding Dysfunction Refractory to α-blocker Therapy: Clinical Characteristics and Predictive Factors.Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.A prospective study of sexual and urinary function before and after total mesorectal excision.Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms.Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction.Holmium Laser Enucleation of the Prostate: Patient Selection and Outcomes.Epidemiology of clinical benign prostatic hyperplasia.Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study
P2860
Q24632629-F32AC055-710C-4DB0-8E98-9AF8C17731A2Q33737556-2725282F-6734-42DC-B8E7-64D7CCB1C84EQ33866212-A33A1C71-31EB-4D2A-A149-C914E0DD359AQ34428486-6FD3F4FD-8209-445E-B2A3-0D2F6FCAFDDCQ35157924-27057DF6-CC53-4D60-A29C-F7F1C934FAD5Q35228167-548CB800-1B27-43F5-B174-D0977A693A88Q37065577-7F129231-1711-4B91-BA54-7F21035B630EQ37069282-015DD4C4-1B5F-462B-930E-E0AD6F8969E0Q37707763-AB2292D1-02AB-4D34-BBF3-151291B23812Q38093143-1ED06258-2760-482C-8F31-136E14B29980Q38649444-AB02AB7B-C065-42CE-A75C-8A659F1350D0Q38846845-133AB5F5-BAEA-48FB-87FA-B0577693FE3EQ38896687-9C7F1906-02E3-422B-9AC9-71AE7A5EB29EQ39138372-BD3765F7-3D09-48D1-AA12-32CEC0C1869AQ39330608-732DE99F-EA7D-4009-9636-BDB3AFCDFF74Q39998486-372C9C3B-5F90-41FE-9D1E-39D94D847700Q41716252-F623D539-782C-4949-B089-5845F317E139Q42373112-62F0A9C0-78D0-449A-B9D5-6E8E54AE88E6Q43017909-70659B79-88AD-479C-91FB-41F65E1D2186Q44888611-E47F8E8C-B64D-4E29-9909-C357CF232D30Q46225179-079D9D38-AE87-49CC-8C5B-2E1B00955BC3Q46969907-9CB0D8A5-403A-4161-B5DA-2D3974CD7FCAQ48007367-4A176321-B3AB-48E6-805E-7067A8F0C490Q48067038-13D1B23D-EE9A-4827-8F38-781E7D829047Q48176290-ABCD25F2-4FFD-40B8-AE7B-1578F32A106FQ48696860-13F7CFDB-5876-4DC1-9D0D-47418B521232Q48852089-C1C64B48-C30E-4315-B8D2-8CF2804E8988Q49478541-CAD2C501-0669-4FC0-BCCC-BEBC631CAAC3Q49583766-71B1DC80-7B72-40B1-99A6-95EDAB3AE0DBQ50092014-BE67E192-C8E8-4B8A-A187-732F42783294Q51776590-5DF2FE75-1092-4D3C-BB36-322A5353DEABQ52575771-3C7540F7-2416-4627-BF5A-B095FB1A13ACQ55019942-CADD0A53-5A14-480E-B236-EC84D4DB6D78Q58555990-52CAA182-BA85-4F5D-BCF9-22325312D436
P2860
Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@ast
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@en
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@nl
type
label
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@ast
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@en
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@nl
prefLabel
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@ast
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@en
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@nl
P2093
P356
P1433
P1476
Cumulative prevalence of prost ...... benign prostatic hyperplasia.
@en
P2093
P304
P356
10.1002/PROS.2990170308
P577
1990-01-01T00:00:00Z